Abstract
The expression of vitamin D receptors (VDR) and growth inhibition induced by 1,25-dihydroxyvitamin D3 have been noted in certain human malignant melanoma cell lines. In this study, widely disparate levels of VDR mRNA expression were demonstrated in a panel of eight human malignant melanoma cell lines. Quantitation of receptor level by ligand binding assay showed a similar pattern. Proliferation and growth curve analysis was performed in two cell lines: RPMI 7951 (high VDR) and SK-MEL-28 (low VDR). Significant growth inhibition was noted in RPMI 7951 cells at 10-9 M 1,25-dihydroxyvitamin D3. SK-MEL-28 cells, which express much lower levels of VDR, did not show any growth inhibition except at extremely high concentrations of 1,25- dihydroxyvitamin D3, namely 10-6 M. These findings suggest a receptor- mediated mechanism of growth inhibition for 1,25-dihydroxyvitamin D3 and a role for this hormone in the growth of malignant melanoma cells.
Cite
CITATION STYLE
Evans, S. R. T., Houghton, A. M., Schumaker, L., Brenner, R. V., Buras, R. R., Davoodi, F., … Shabahang, M. (1996). Vitamin D receptor and growth inhibition by 1,25-dihydroxyvitamin D3 in human malignant melanoma cell lines. Journal of Surgical Research, 61(1), 127–133. https://doi.org/10.1006/jsre.1996.0092
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.